This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2001;286:527.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The FDA has approved the Lap-Band Adjustable Gastric Banding System (BioEnterics Corp, Carpinteria, Calif) for use in weight reduction for severely obese patients. The approved indication is limited to patients with a body mass index (BMI) of at least 40 kg/m²; with a BMI of at least 35 kg/m² with one or more severe conditions, such as hypertension or gallstone disease; or who weigh at least 100 lb more than their estimated ideal weight according to the 1983 Metropolitan Life Insurance Tables. The system is indicated for use only in adult patients in whom more conservative weight-reduction alternatives have failed and who make a commitment to accept significant changes in their lifestyle, such as reduced food consumption and daily exercise.

The main component of the system, a 13-mm-wide plastic band, is laparoscopically placed around the stomach, allowing the formation of a small gastric pouch and stoma. Inflated through an . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?